These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 3574316)

  • 21. Antigen F1 from Yersinia pestis forms aqueous channels in lipid bilayer membranes.
    Rodrigues CG; Carneiro CM; Barbosa CT; Nogueira RA
    Braz J Med Biol Res; 1992; 25(1):75-9. PubMed ID: 1284806
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multiple antigen peptide containing B and T cell epitopes of F1 antigen of Yersinia pestis showed enhanced Th1 immune response in murine model.
    Ali R; Naqvi RA; Kumar S; Bhat AA; Rao DN
    Scand J Immunol; 2013 May; 77(5):361-71. PubMed ID: 23480362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The physicochemical and biological characteristics of the Yersinia pestis pH 6 antigen isolated by an immunosorption method].
    Stepanshina VN; Gremiakova TA; Anisimov AP; Potapov VD
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (3):12-7. PubMed ID: 8067083
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemical composition and biological activity of the Yersinia pestis envelope substance.
    Głosnicka R; Gruszkiewicz E
    Infect Immun; 1980 Nov; 30(2):506-12. PubMed ID: 7002800
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Macromolecular organization of the Yersinia pestis capsular F1 antigen: insights from time-of-flight mass spectrometry.
    Tito MA; Miller J; Griffin KF; Williamson ED; Titball RW; Robinson CV
    Protein Sci; 2001 Nov; 10(11):2408-13. PubMed ID: 11604546
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Recombinant plasmids carrying yersinia pestis fra-operon: specific features of genetic transmission, inheritance and expression in attenuated enterobacterial cells].
    Fursova NK; Krasil'nikova VM; Gremiakova TA
    Vestn Ross Akad Med Nauk; 1997; (6):44-7. PubMed ID: 9289280
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Structural and functional properties and the biological activity of Yersinia pestis capsular antigen, murine toxin and endotoxin].
    Isin ZhM; Tugambaev TI
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Apr; (4):91-8. PubMed ID: 3300112
    [No Abstract]   [Full Text] [Related]  

  • 28. [Design of a Yersinia pestis strain with increased protection].
    Anisimov AP; Nikiforov AK; Eremin SA; Drozdov IG
    Biull Eksp Biol Med; 1995 Nov; 120(11):532-4. PubMed ID: 8713337
    [No Abstract]   [Full Text] [Related]  

  • 29. [The detection and characteristics of the Yersinia pestis antigen exhibiting the properties of S-layer proteins].
    Diatlov IA; Antonova OA
    Zh Mikrobiol Epidemiol Immunobiol; 1999; (4):90-1. PubMed ID: 10852065
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunochemical characterization of Fraction I of Yersinia pestis strains by CAF1M gene].
    Fedorova VA; Devdariani ZL
    Mol Gen Mikrobiol Virusol; 2002; (1):11-7. PubMed ID: 11904918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MAP of F1 and V antigens from Yersinia pestis astride innate and adaptive immune response.
    Rai R; Das B; Choudhary N; Talukdar A; Rao DN
    Microb Pathog; 2015 Oct; 87():13-20. PubMed ID: 26188288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nucleotide sequence of the Yersinia pestis gene encoding F1 antigen and the primary structure of the protein. Putative T and B cell epitopes.
    Galyov EE; Smirnov OYu ; Karlishev AV; Volkovoy KI; Denesyuk AI; Nazimov IV; Rubtsov KS; Abramov VM; Dalvadyanz SM; Zav'yalov VP
    FEBS Lett; 1990 Dec; 277(1-2):230-2. PubMed ID: 1702734
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A cyclic 3',5'-adenosine monophosphate-binding protein in the causative agent of plague].
    Shevchenko LA; Mishan'kin BN
    Mikrobiol Zh (1978); 1990; 52(4):33-40. PubMed ID: 2177132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutagenesis elucidates the assembly pathway and structure of Yersinia pestis F1 polymer.
    Kersley JE; Zavialov AV; Moslehi E; Knight SD; MacIntyre S
    Adv Exp Med Biol; 2003; 529():113-6. PubMed ID: 12756739
    [No Abstract]   [Full Text] [Related]  

  • 35. [Cloning and detailed mapping of the fra-ymt region of the Yersinia pestis pFra plasmid].
    Cherepanov PA; Mikhaĭlova TG; Karimova GA; Zakharova NM; Ershov IuV; Volkovoĭ KI
    Mol Gen Mikrobiol Virusol; 1991 Dec; (12):19-26. PubMed ID: 1787840
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Design and testing for a nontagged F1-V fusion protein as vaccine antigen against bubonic and pneumonic plague.
    Powell BS; Andrews GP; Enama JT; Jendrek S; Bolt C; Worsham P; Pullen JK; Ribot W; Hines H; Smith L; Heath DG; Adamovicz JJ
    Biotechnol Prog; 2005; 21(5):1490-510. PubMed ID: 16209555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-mediated immune response and Th/Th cytokine profile of B-T constructs of F1 and V antigen of Yersinia pestis.
    Gupta G; Khan AA; Rao DN
    Scand J Immunol; 2010 Mar; 71(3):186-98. PubMed ID: 20415784
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Purification and characterization of a recombinant Yersinia pestis V-F1 "Reversed" fusion protein for use as a new subunit vaccine against plague.
    Goodin JL; Powell BS; Enama JT; Raab RW; McKown RL; Coffman GL; Andrews GP
    Protein Expr Purif; 2011 Mar; 76(1):136-44. PubMed ID: 21055471
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Large-scale purification of the F1 antigen of Yersinia pestis.
    Reddin KM; Easterbrook TJ; Robinson A; Williamson D; Rhind-tutt R
    Contrib Microbiol Immunol; 1995; 13():329-30. PubMed ID: 8833865
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antigen biosynthesis during the limitation of Yersinia pestis growth].
    Krivachenko KB
    Zh Mikrobiol Epidemiol Immunobiol; 2000; (1):86-8. PubMed ID: 10876906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.